4974 — Takara Bio Cashflow Statement
0.000.00%
Last trade - 00:00- ¥140bn
- ¥106bn
- ¥44bn
- 81
- 28
- 34
- 44
Annual cashflow statement for Takara Bio, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 5,433 | 13,552 | 27,532 | 21,224 | 2,853 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 874 | 722 | 473 | -479 | 293 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3,386 | -4,039 | -25,074 | 11,502 | -6,353 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 6,338 | 13,941 | 6,985 | 36,896 | 1,712 |
| Capital Expenditures | -4,052 | -8,845 | -12,539 | -5,882 | -12,872 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 3,840 | 5,067 | 5,468 | -811 | -171 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -212 | -3,778 | -7,071 | -6,693 | -13,043 |
| Financing Cash Flow Items | -1 | -1 | — | — | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -946 | -1,103 | -2,070 | -4,119 | -5,233 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 4,998 | 8,845 | -1,148 | 26,897 | -15,886 |